We aim to regenerate biological tissues for patients having medical conditions that involve complete or partial tissue loss or dysfunction. As biomaterials have shown supremacy in tissue repair and regeneration with comparatively high compatibility with the native extracellular matrix (ECM). Here, we propose to develop biomimetic and drug-eluting biomaterial based scaffolds and bio-inks to fulfil the current clinical need of multifunctional scaffolds to repair large tissue defects in tissue engineering. Biomaterials of my research interest are polysaccharides (kappa-carrageenan, chitosan, hyaluronic acid, and alginate) and proteins (silk fibroin, gelatin, and collagen).